Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04874506
Title MBM-02 (Tempol) for the Treatment of Glioblastoma Multiforme (GBM)
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Matrix Biomed, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Georgetown Washington District of Columbia 20007 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field